Julia R Brown Net Worth

The estimated Net Worth of Julia R Brown is at least $24.8 Mille dollars as of 7 June 2018. Julia Brown owns over 3,333 units of Cytocom Inc stock worth over $24,831 and over the last 12 years Julia sold CBLI stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Julia Brown CBLI stock SEC Form 4 insiders trading

Julia has made over 2 trades of the Cytocom Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Julia exercised 3,333 units of CBLI stock worth $29,997 on 7 June 2018.

The largest trade Julia's ever made was exercising 4,500 units of Cytocom Inc stock on 7 June 2018 worth over $78,975. On average, Julia trades about 870 units every 0 days since 2013. As of 7 June 2018 Julia still owns at least 7,833 units of Cytocom Inc stock.

You can see the complete history of Julia Brown stock trades at the bottom of the page.

What's Julia Brown's mailing address?

Julia's mailing address filed with the SEC is C/O CLEVELAND BIOLABS, INC., 73 HIGH STREET, BUFFALO, NY, 14203.

Insiders trading at Cytocom Inc

Over the last 17 years, insiders at Cytocom Inc have traded over $1,157,190 worth of Cytocom Inc stock and bought 66,403 units worth $199,902 . The most active insiders traders include James Antal, Michael Fonstein e Bernard L Kasten. On average, Cytocom Inc executives and independent directors trade stock every 101 days with the average trade being worth of $21,921. The most recent stock trade was executed by Langdon L Miller on 22 July 2021, trading 10,000 units of CBLI stock currently worth $30,000.

What does Cytocom Inc do?

Complete history of Julia Brown stock trades at Albireo Pharma Inc e Cytocom Inc

Cytocom Inc executives and stock owners

Cytocom Inc executives and other stock owners filed with the SEC include:

• Christopher Zosh,
  Interim Principal Executive Officer and Principal Financial Officer, Vice President of Finance
• Langdon Miller,
  President, Chief Medical Officer
• Andrei Gudkov,
  Chief Scientific Officer
• Lea Verny,
  Independent Chairman of the Board
• Daniil Talyanskiy,
  Independent Director
• Randy Saluck,
  Independent Director
• Anna Evdokimova,
  Independent Director
• Alexander Andryushechkin,
  Independent Director
• Ivan Fedyunin,
  Independent Director
• Anthony Principi,
  Director
• C Neil Lyons,
  Chief Financial Officer
• Elena Kasimova,
  Director
• Yakov Kogan,
  EVP of Bus. Development, Sec.
• Richard Mc Gowan,
  Director
• James Antal,
  Director
• Daniel Floyd Jr Hoth,
  Director
• Julia R Brown,
  Director
• Alexander Polinsky,
  Director
• David C Hohn,
  Director
• Bernard L Kasten,
  Director
• Jean Viallet,
  Chief Development Officer
• Paul E Di Corleto,
  Director
• Michael Fonstein,
  CEO & President
• Hector Daniel Perez,
  Director
• John A Jr Marhofer,
  Chief Financial Officer
• Securities Corp Sunrise,
  10% owner
• Michael K Handley,
  President and CEO
• Robert Buckheit,
  Chief Technology Officer
• Cozette M. Mc Avoy,
  Chief Legal Officer
• Clifford Selsky,
  Chief Medical Officer
• Peter Aronstam,
  Chief Financial Officer